Woongjin Co., Ltd. (KRX:016880)
2,805.00
-5.00 (-0.18%)
Last updated: Apr 29, 2026, 2:14 PM KST
Woongjin Revenue
In the year 2025, Woongjin had annual revenue of 1.15T KRW with 14.14% growth. Woongjin had revenue of 313.00B in the quarter ending December 31, 2025, with 22.71% growth.
Revenue
1,150.69B
Revenue Growth
+14.14%
P/S Ratio
0.19
Revenue / Employee
1.24B
Employees
928
Market Cap
218.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,150.69B | 142.58B | 14.14% |
| Dec 31, 2024 | 1,008.11B | -10.47B | -1.03% |
| Dec 31, 2023 | 1,018.58B | -31.26B | -2.98% |
| Dec 31, 2022 | 1,049.84B | 69.98B | 7.14% |
| Dec 31, 2021 | 979.87B | 93.63B | 10.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HS HYOSUNG | 1,409.90B |
| Gridwiz | 125.61B |
| JLK, Inc. | 3.34B |
| KPX Holdings | 1,163.73B |
| KG Chemical | 9,101.65B |
| HLB GLOBAL | 100.29B |
| Samyang Holdings | 3,348.29B |
| Aprogen Medicines | 117.97B |